A user began a regimen of BPC-157 and TB-500 with the goals of anti-aging and reducing inflammation. They reported being new to self-injections and decided against intra-articular administration after researching its limited effectiveness.
A user began a regimen of BPC-157 and TB-500 with the goals of anti-aging and reducing inflammation. They reported being new to self-injections and decided against intra-articular administration after researching its limited effectiveness.